Original Article

You have free access to this content

Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation

  1. Stephanie Campbell BA1,
  2. Can-Lan Sun PhD1,
  3. Seira Kurian MD, MPH1,
  4. Liton Francisco BS1,
  5. Andrea Carter BA1,
  6. Sameer Kulkarni MS2,
  7. Pablo Parker MD3,
  8. Chatchada Karanes MD3,
  9. Stephen J. Forman MD3,
  10. Smita Bhatia MD, MPH1,†,*

Article first published online: 17 JUN 2009

DOI: 10.1002/cncr.24474

Issue

Cancer

Cancer

Volume 115, Issue 18, pages 4127–4135, 15 September 2009

Additional Information

How to Cite

Campbell, S., Sun, C.-L., Kurian, S., Francisco, L., Carter, A., Kulkarni, S., Parker, P., Karanes, C., Forman, S. J. and Bhatia, S. (2009), Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer, 115: 4127–4135. doi: 10.1002/cncr.24474

Author Information

  1. 1

    Department of Population Sciences, City of Hope National Medical Center, Duarte, California

  2. 2

    Albert Einstein College of Medicine, Bronx, New York

  3. 3

    Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California

  1. †

    Fax: (626) 301-8978

*Department of Population Sciences, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010-3000

Publication History

  1. Issue published online: 4 SEP 2009
  2. Article first published online: 17 JUN 2009
  3. Manuscript Accepted: 31 DEC 2008
  4. Manuscript Revised: 26 NOV 2008
  5. Manuscript Received: 11 SEP 2008

Funded by

  • National Institutes of Health. Grant Number: R01CA078938
  • Lymphoma/Leukemia Society Scholar Award. Grant Number: 2191-02

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (176K)

References

  • 1
    Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002; 32: 94-124.
  • 2
    Chang CC, Greenspan A, Gershwin ME. Osteonecrosis: current perspectives on pathogenesis and treatment. Semin Arthritis Rheum. 1993; 23: 47-69.
  • 3
    Kerachian MA, Harvey EJ, Cournoyer D, Chow TYK, Seguin C. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium. 2006; 13: 237-244.
  • 4
    Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine. 2006; 73: 500-507.
  • 5
    Burger B, Beier R, Zimmermann M, Beck JD, Reiter A, Schrappe M. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)—experiences from trial ALL-BFM 95. Pediatr Blood Cancer. 2005; 44: 220-225.
    Direct Link:
  • 6
    Mattano LAJr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol. 2000; 18: 3262-3272.
  • 7
    Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol. 2001; 19: 3066-3072.
  • 8
    Enright H, Haake R, Weisdorf D. Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med. 1990; 89: 733-738.
  • 9
    Fink JC, Leisenring WM, Sullivan KM, Sherrard DJ, Weiss NS. Avascular necrosis following bone marrow transplantation: a case-control study. Bone. 1998; 22: 67-71.
  • 10
    Schulte CM, Beelen DW. Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter. Transplantation. 2004; 78: 1055-1063.
  • 11
    Socie G, Selimi F, Sedel L, et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. Br J Haematol. 1994; 86: 624-628.
    Direct Link:
  • 12
    Socie G, Cahn JY, Carmelo J, et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM). Br J Haematol. 1997; 97: 865-870.
    Direct Link:
  • 13
    Socie G, Loiseau P, Tamouza R, et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation. 2001; 72: 699-706.
  • 14
    Tauchmanova L, De Rosa G, Serio B, et al. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review. Cancer. 2003; 97: 2453-2461.
    Direct Link:
  • 15
    Torii Y, Hasegawa Y, Kubo T, et al. Osteonecrosis of the femoral head after allogeneic bone marrow transplantation. Clin Orthop Relat Res. 2001;( 382): 124-132.
  • 16
    Koc S, Leisenring W, Flowers ME, et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood. 2002; 100: 48-51.
  • 17
    Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999; 18: 695-706.
    Direct Link:
  • 18
    Cox D. Regression models and life tables. J R Stat Soc. 1972; B: 187-220.
  • 19
    Cruess RL. Cortisone-induced avascular necrosis of the femoral head. J Bone Joint Surg Br. 1977; 59: 308-317.
  • 20
    Fryer JP, Granger DK, Leventhal JR, Gillingham K, Najarian JS, Matas AJ. Steroid-related complications in the cyclosporine era. Clin Transplant. 1994; 8: 224-229.
  • 21
    Tang S, Chan TM, Lui SL, Li FK, Lo WK, Lai KN. Risk factors for avascular bone necrosis after renal transplantation. Transplant Proc. 2000; 32: 1873-1875.
  • 22
    Zalavras CG, Vartholomatos G, Dokou E, Malizos KN. Genetic background of osteonecrosis: associated with thrombophilic mutations? Clin Orthop Relat Res. 2004; ( 422): 251-255.
  • 23
    Goffin E, Devogelaer JP. Bone disorders after organ transplantation. Transplant Proc. 2005; 37: 2832-2833.
  • 24
    Sakai T, Sugano N, Kokado Y, Takahara S, Ohzono K, Yoshikawa H. Tacrolimus may be associated with lower osteonecrosis rates after renal transplantation. Clin Orthop. 2003: 163-170.
  • 25
    Stern JM, Sullivan KM, Ott SM, et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol Blood Marrow Transplant. 2001; 7: 257-264.
  • 26
    Abbott KC, Koff J, Bohen EM, et al. Maintenance immunosuppression use and the associated risk of avascular necrosis after kidney transplantation in the United States. Transplantation. 2005; 79: 330-336.
  • 27
    Gopal AK, Thorning DR, Back AL. Fatal outcome due to cyclosporine neurotoxicity with associated pathological findings. Bone Marrow Transplant. 1999; 23: 191-193.
  • 28
    Jumani A, Hala K, Tahir S, et al. Causes of acute thrombotic microangiopathy in patients receiving kidney transplantation. Exp Clin Transplant. 2004; 2: 268-272.
  • 29
    Nadir Y, Hoffman R, Brenner B. Drug-related thrombosis in hematologic malignancies. Rev Clin Exp Hematol. 2004; 8: E4.
  • 30
    Mathis AS, Dave N, Knipp GT, Friedman GS. Drug-related dyslipidemia after renal transplantation. Am J Health Syst Pharm. 2004; 61: 565-585; quiz 586-587.
  • 31
    Fortin MC, Raymond MA, Madore F, et al. Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination. Am J Transplant. 2004; 4: 946-952.
    Direct Link:
  • 32
    Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood. 1989; 73: 2018-2024.
  • 33
    Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant. 1994; 14: 495-504.
  • 34
    Pizzolato GP, Sztajzel R, Burkhardt K, Megret M, Borisch B. Cerebral vasculitis during FK 506 treatment in a liver transplant patient. Neurology. 1998; 50: 1154-1157.
View Full Article (HTML) Get PDF (176K)